258 related articles for article (PubMed ID: 19483629)
21. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
Osman H; Cheng L; Ulbright TM; Idrees MT
Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
[TBL] [Abstract][Full Text] [Related]
22. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
[TBL] [Abstract][Full Text] [Related]
23. The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture.
Perrett RM; Turnpenny L; Eckert JJ; O'Shea M; Sonne SB; Cameron IT; Wilson DI; Rajpert-De Meyts E; Hanley NA
Biol Reprod; 2008 May; 78(5):852-8. PubMed ID: 18199879
[TBL] [Abstract][Full Text] [Related]
24. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.
Rabban JT; Zaloudek CJ
Histopathology; 2013 Jan; 62(1):71-88. PubMed ID: 23240671
[TBL] [Abstract][Full Text] [Related]
25. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.
Fichtner A; Richter A; Filmar S; Kircher S; Rosenwald A; Küffer S; Nettersheim D; Oing C; Marx A; Ströbel P; Bremmer F
Histopathology; 2022 Jan; 80(2):381-396. PubMed ID: 34506648
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.
Trinh DT; Shibata K; Hirosawa T; Umezu T; Mizuno M; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2012 May; 38(5):841-8. PubMed ID: 22448662
[TBL] [Abstract][Full Text] [Related]
27. Podoplanin, a novel marker for seminoma: A comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4.
Idrees M; Saxena R; Cheng L; Ulbright TM; Badve S
Ann Diagn Pathol; 2010 Oct; 14(5):331-6. PubMed ID: 20850695
[TBL] [Abstract][Full Text] [Related]
28. Changes in the methylation status of the Oct3/4, Nanog, and Sox2 promoters in stem cells during regeneration of rat tracheal epithelium after injury.
Zhou Y; Song N; Li X; Han Y; Ren Z; Xu JX; Han YC; Li F; Jia X
Oncotarget; 2017 Jan; 8(2):2984-2994. PubMed ID: 27935870
[TBL] [Abstract][Full Text] [Related]
29. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
Lau SK; Weiss LM; Chu PG
Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
[TBL] [Abstract][Full Text] [Related]
30. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
[TBL] [Abstract][Full Text] [Related]
31. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
32. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
33. Podoplanin: a novel diagnostic immunohistochemical marker.
Ordóñez NG
Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
[TBL] [Abstract][Full Text] [Related]
34. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
35. NANOG priming before full reprogramming may generate germ cell tumours.
Grad I; Hibaoui Y; Jaconi M; Chicha L; Bergström-Tengzelius R; Sailani MR; Pelte MF; Dahoun S; Mitsiadis TA; Töhönen V; Bouillaguet S; Antonarakis SE; Kere J; Zucchelli M; Hovatta O; Feki A
Eur Cell Mater; 2011 Nov; 22():258-74; discussio 274. PubMed ID: 22071697
[TBL] [Abstract][Full Text] [Related]
36. Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.
Virant-Klun I; Kenda-Suster N; Smrkolj S
J Ovarian Res; 2016 Mar; 9():12. PubMed ID: 26940129
[TBL] [Abstract][Full Text] [Related]
37. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
38. Expression of Transcription Factors and Nuclear Receptors in Mixed Germ Cell-Sex Cord Stromal Tumor and Related Tumors of the Gonads.
Roth LM; Cheng L
Int J Gynecol Pathol; 2015 Nov; 34(6):528-34. PubMed ID: 26107563
[TBL] [Abstract][Full Text] [Related]
39. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
[TBL] [Abstract][Full Text] [Related]
40. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers.
Weissferdt A; Rodriguez-Canales J; Liu H; Fujimoto J; Wistuba II; Moran CA
Hum Pathol; 2015 Mar; 46(3):376-83. PubMed ID: 25576290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
